How much does Wegovy cost without insurance?

List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).

Does insurance cover Zepbound?

Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.

Is Ozempic the same as Wegovy?

Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.

Can I still get compounded GLP-1 in 2026?

For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.

How does Wegovy compare to Saxenda?

Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Provider review

Ro

Item: Ro
Rating: 4.4
Author: Dr. Jane Novak

Direct-to-consumer GLP-1 program with broad medication selection and a polished app.

Medically reviewed by Dr. Jane Novak, MD, MPH 6 min read Fact checked Editorial integrityUpdated May 24, 2026

4.40/5 rating
From $99.00/mo
51 states
2 GLP-1s

Medically reviewed by Dr. Jane Novak, MD, MPH on May 24, 2026

Rating breakdown

How this provider scored, per dimension

Editorial scores out of 5 — see our scoring rubric for the criteria behind each axis.

Overall: 4.4/5
Pricing: 4.2/5
Patient experience: 4.6/5
Delivery speed: —/5
Customer support: —/5
Billing clarity: —/5

Who's behind this provider

Company snapshot

Founded: 2017 (9 years old)
Headquarters: New York, NY
Leadership: Zachariah Reitano; CEO + co-founder
Total funding raised: $876M
Prescriber employment: W-2 employed clinicians

Source: ro.co/about + Crunchbase. Last verified 2026-04-12. Funding figures are cumulative disclosed raises; private-company numbers may lag the live cap table by 1 round.

Ro provider review — Ro is a GLP-1 telehealth provider operating in 51 U.S. states.Photo: Unsplash

From

$99/mo

Medications

States

Rating

4.4/5

Visit Ro Compare alternatives

We earn a commission if you sign up through this link. Editorial ranking is independent.

What we liked

Compounded options keep cost low
Polished iOS/Android app
Pharmacy ships fast

What gave us pause

Cash-pay only
Compounded availability changes quarterly

Reader reviews

Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.

No user reviews yet

Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.

Ready to try Ro?

From $99.00/mo. Commission-funded, editorially independent.

Get started with Ro

How to get started with Ro Start a Ro consultation

Common questions readers ask

How much does Wegovy cost without insurance?: List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).
Does insurance cover Zepbound?: Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.
Is Ozempic the same as Wegovy?: Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.
Can I still get compounded GLP-1 in 2026?: For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.
How does Wegovy compare to Saxenda?: Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Was this page helpful?